Wieland D Müskens
4PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 23, 2025
Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do Matter.Amy C D Peeters, Maike H M Wientjes, Wieland D Müskens
|Mar 10, 2021
Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization.Wieland D Müskens, Sanne A A Rongen-van Dartel, Carine Vogel
|Nov 02, 2020
Does Etanercept Biosimilar Prescription in a Rheumatology Center Bend the Medication Cost Curve?Wieland D Müskens, Sanne A A Rongen-van Dartel, Piet L C M van Riel
|Oct 02, 2020
One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology.Wieland D Müskens, Sanne A A Rongen-van Dartel, Steven Teerenstra
Pageof 1
Frequent Collaborators
3 joint publications
Sanne A A Rongen-van Dartel
3 joint publications
Eddy M M Adang
3 joint publications
Piet L C M van Riel
1 joint publications
Steven Teerenstra
1 joint publications
Anita Huis
1 joint publications
Amy C D Peeters
1 joint publications
Maike H M Wientjes
1 joint publications
David F Ten Cate
1 joint publications
Laura C Coates
1 joint publications
Bart J F van den Bemt
